Browsing Institutt for klinisk medisin by Author "Fadnes, Lars T"
Now showing items 1-7 of 7
-
Vold, Jørn H; Aas, Christer; Skurtveit, Svetlana; Odsbu, Ingvild; Chalabianloo, Fatemeh; Halmøy, Anne; Johansson, Kjell A; Fadnes, Lars T (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2020)Background It is estimated that up to a third of patients on opioid agonist therapy (OAT) have attention deficit hyperactivity disorder (ADHD). Treatment by ADHD medication, including a centrally acting ...
-
Vold, Jørn H; Skurtveit, Svetlana; Aas, Christer; Chalabianloo, Fatemeh; Kloster, Pia S; Johansson, Kjell A; Fadnes, Lars T (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2020)Background Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients on opioid agonist therapy (OAT) are common and have pros and cons. The objectives of the current study are to define the dispensation ...
-
Aas, Christer F; Vold, Jørn H; Skurtveit, Svetlana; Lim, Aaron G; Ruths, Sabine; Islam, Kamrul; Askildsen, Jan E; Løberg, Else-Marie; Fadnes, Lars T; Johansson, Kjell A (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2020)Background Opioid dependence carries the highest disease burden of all illicit drugs. Opioid agonist therapy (OAT) is an evidence-based medical intervention that reduces morbidity and mortality. There is limited knowledge ...
-
Vold, Jørn H; Gjestad, Rolf; Aas, Christer F; Chalabianloo, Fatemeh; Skurtveit, Svetlana; Løberg, Else-Marie; Johansson, Kjell A; Fadnes, Lars T (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2020)Background The impact of clinical and sociodemographic factors on fatigue remains unknown among patients with substance use disorders (SUD). This study aims to evaluate fatigue among patients with SUD using ...
-
Fadnes, Lars T; Aas, Christer F; Vold, Jørn H; Ohldieck, Christian; Leiva, Rafael A; Chalabianloo, Fatemeh; Skurtveit, Svetlana; Lygren, Ole J; Dalgård, Olav; Vickerman, Peter; Midgard, Håvard; Løberg, Else-Marie; Johansson, Kjell A (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2019)Background A large proportion of people who inject drugs (PWID) living with hepatitis C virus (HCV) infection have not been treated. It is unknown whether inclusion of HCV diagnostics and treatment into ...
-
Vold, Jørn H; Skurtveit, Svetlana; Aas, Christer; Johansson, Kjell A; Fadnes, Lars T (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2020)Background Dispensations of opioid analgesics to patients on opioid agonist therapy (OAT) may increase the risk of overdoses. The current study’s objectives are to investigate the dispensation rates and mean daily doses ...
-
Aas, Christer F; Vold, Jørn H; Skurtveit, Svetlana; Odsbu, Ingvild; Chalabianloo, Fatemeh; Lim, Aaron G; Johansson, Kjell A; Fadnes, Lars T (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2020)Background Treatment with direct-acting antiviral agents (DAAs) offers an opportunity to eliminate hepatitis C virus (HCV) endemic among people who inject drugs (PWID) and people enrolled in opioid agonist therapy (OAT) ...